---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-182860"
form_type: "8-K"
ticker: "LYRA"
cik: "0001327273"
company_name: "Lyra Therapeutics, Inc."
filed_at: "2024-07-23T23:59:59+00:00"
generated_at: "2026-05-31T17:51:45.711717+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lyra Therapeutics receives Nasdaq minimum bid price deficiency notice; has until Jan 15, 2025 to cure

## Summary
- Nasdaq notified Lyra on July 19, 2024 that its common stock (LYRA) closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until January 15, 2025, to regain compliance by closing at or above $1.00 for 10 consecutive days.
- If not cured, Lyra may transfer to Nasdaq Capital Market and get an additional 180-day compliance period.
- Failure to regain compliance could result in delisting; the company intends to monitor and consider available options.
- Stock continues trading on Nasdaq Global Market under symbol LYRA during the cure period.

## SEC filing metadata
- accession: 0001193125-24-182860
- form_type: 8-K
- ticker: LYRA
- cik: 0001327273
- company_name: Lyra Therapeutics, Inc.
- filed_at: 2024-07-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1327273/000119312524182860/0001193125-24-182860-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1327273/000119312524182860/d871197d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-182860
- JSON: https://secwatch.observer/filing/0001193125-24-182860.json
- Plain text: https://secwatch.observer/filing/0001193125-24-182860.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.